These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
797 related articles for article (PubMed ID: 18768529)
1. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP). Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529 [TBL] [Abstract][Full Text] [Related]
2. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation. Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F; Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Ouachée-Chardin M; Elie C; de Saint Basile G; Le Deist F; Mahlaoui N; Picard C; Neven B; Casanova JL; Tardieu M; Cavazzana-Calvo M; Blanche S; Fischer A Pediatrics; 2006 Apr; 117(4):e743-50. PubMed ID: 16549504 [TBL] [Abstract][Full Text] [Related]
6. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis. Yoon HS; Im HJ; Moon HN; Lee JH; Kim HJ; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Cho B; Kim HK; Lyu CJ; Lee MJ; Kook H; Hwang TJ; Seo JJ Pediatr Transplant; 2010 Sep; 14(6):735-40. PubMed ID: 20113424 [TBL] [Abstract][Full Text] [Related]
7. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation. Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience. Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Fagioli F; Zecca M; Rognoni C; Lanino E; Balduzzi A; Berger M; Messina C; Favre C; Rabusin M; Lo Nigro L; Masetti R; Prete A; Locatelli F; Biol Blood Marrow Transplant; 2012 Jun; 18(6):852-60. PubMed ID: 22019726 [TBL] [Abstract][Full Text] [Related]
10. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematologic malignancies in children. Huang X; Liu D; Liu K; Xu L; Chen H; Han W; Chen Y; Wang Y; Zhang X Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):91-4. PubMed ID: 19147085 [TBL] [Abstract][Full Text] [Related]
11. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study. Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G; Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759 [TBL] [Abstract][Full Text] [Related]
12. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related]
13. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Yu W; Huan C; Yu-Hong C; Wei H; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Feng-Rong W; Fei-Fei T Clin Cancer Res; 2009 Jul; 15(14):4777-83. PubMed ID: 19584148 [TBL] [Abstract][Full Text] [Related]
14. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
15. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis. Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456 [TBL] [Abstract][Full Text] [Related]
16. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Cesaro S; Brugiolo A; Faraci M; Uderzo C; Rondelli R; Favre C; Zecca M; Garetto G; Dini G; Pillon M; Messina C; Zanesco L; Pession A; Locatelli F Bone Marrow Transplant; 2003 Nov; 32(9):925-31. PubMed ID: 14561994 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico. Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953 [TBL] [Abstract][Full Text] [Related]
18. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology. Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386 [TBL] [Abstract][Full Text] [Related]
19. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis. Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187 [TBL] [Abstract][Full Text] [Related]
20. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]